Surgical Nivolumab And Ipilimumab For Recurrent GBM
Clinical trial NCT04606316 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04606316
- Sponsor
- Patrick Wen, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-01
- Primary completion
- 2026-12-30
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.